BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260305
DTSTAMP:20260507T211106
CREATED:20251227T145828Z
LAST-MODIFIED:20251227T145837Z
UID:10000538-1772582400-1772668799@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers : Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC). \nScheduled for March 4\, 2026\, this virtual session focuses on the technical challenges of managing advanced disease where cure is no longer the primary objective\, emphasizing the optimization of medical care through personalized treatment sequencing. This educational event\, chaired by Michiel S. van der Heijden\, is part of the ESMO Deep Dive series\, which utilizes evidence-based data and expert-led discussion to refine clinical decision-making for complex genitourinary oncological cases. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-434709
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260306
DTSTAMP:20260507T211106
CREATED:20251126T003017Z
LAST-MODIFIED:20251126T003058Z
UID:10000405-1772582400-1772755199@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists\, focusing on using precision medicine to manage patients with HR-positive\, HER2-negative metastatic breast cancer. \nThe event is scheduled to take place on March 4–5\, 2026\, in Zurich\, Switzerland. \nThe application deadline for participation is January 7\, 2026\, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing\, using results for optimal patient selection\, and discussing the proactive management of precision-medicine-based treatments. \nApply.
URL:https://oncodaily.com/event/breast-cancer-416477
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-2-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260308
DTSTAMP:20260507T211106
CREATED:20251221T215815Z
LAST-MODIFIED:20251221T215832Z
UID:10000517-1772755200-1772927999@oncodaily.com
SUMMARY:ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. \nScheduled for March 6–7\, 2026\, in Zurich\, Switzerland\, the course focuses on multidisciplinary care\, evidence-based management\, and the interpretation of novel translational research\, including molecular profiling and clinical trials. \nLed by co-chairs Viktor Gruenwald and Bernadett Szabados\, the program offers successful applicants complimentary registration\, accommodation\, and a travel grant\, emphasizing ESMO’s commitment to advancing professional expertise in bladder cancer treatment. \nApplication.
URL:https://oncodaily.com/event/esmo-432406
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260314
DTSTAMP:20260507T211106
CREATED:20251126T122443Z
LAST-MODIFIED:20251126T122508Z
UID:10000407-1773187200-1773446399@oncodaily.com
SUMMARY:ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
DESCRIPTION:The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13\, 2026\, in Manchester\, United Kingdom. \nThe application deadline is January 21\, 2026\, at 23:59 CET\, and the course is accredited for 16 ESMO-MORA category 1 points. \nThe learning objectives cover the full spectrum of thoracic oncology\, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC)\, with a focus on advanced treatments like targeted agents for actionable driver mutations\, novel immunotherapies\, and palliative care. \nApply.
URL:https://oncodaily.com/event/esmo-the-christie-preceptorship416745
LOCATION:Manchester\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-Christie.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20260312T080000
DTEND;TZID=Europe/Zurich:20260314T170000
DTSTAMP:20260507T211106
CREATED:20250710T195346Z
LAST-MODIFIED:20250710T195614Z
UID:10000209-1773302400-1773507600@oncodaily.com
SUMMARY:The ESMO Sarcoma and Rare Cancers Congress 2026
DESCRIPTION:The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano\, Switzerland\, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. \nThe congress will discuss the latest developments in diagnosis\, treatment\, molecular biology\, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations\, educational lectures\, multidisciplinary tumour boards\, guidelines updates\, and dedicated discussions for young oncologists. With opportunities for clinicians\, researchers\, industry professionals\, and patient advocates to connect and collaborate\, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.
URL:https://oncodaily.com/event/esmo-326996
LOCATION:“Palazzo dei Congressi” in Lugano\, Switzerland\, Piazza Indipendenza 4\, Lugano\, 6900\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7057.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260316
DTEND;VALUE=DATE:20260319
DTSTAMP:20260507T211106
CREATED:20251114T213627Z
LAST-MODIFIED:20251114T213641Z
UID:10000355-1773619200-1773878399@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Congress 2026
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO)\, focused on accelerating the delivery of life-changing anticancer therapies through early drug development. \nThe congress will be held from March 16 to 18\, 2026\, at the Palais des Congrès in Paris\, France. The event serves as a dynamic\, multi-stakeholder meeting\, uniting researchers\, industry leaders\, investors\, and regulators to share new data\, foster collaboration\, and tackle the challenges of advancing early clinical development in oncology. \nElena Garralda\, Carlos Gomez-Roca\, and Cristian Massacesi serve as the co-chairs.
URL:https://oncodaily.com/event/esmo-409793
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7078.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260319T080000
DTEND;TZID=Europe/Madrid:20260321T170000
DTSTAMP:20260507T211106
CREATED:20250719T103826Z
LAST-MODIFIED:20250801T203138Z
UID:10000223-1773907200-1774112400@oncodaily.com
SUMMARY:The ICHNO 2026
DESCRIPTION:The ICHNO 2026\, the 10th International Congress on Innovative Approaches in Head and Neck Oncology\, will be held from 19–21 March 2026 in Seville\, Spain\, under the theme: “Driven by Biology\, Centred on the Person.”  \nThis unique event—jointly organized by ESTRO\, EHNS\, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology\, grounded in biology and focused on the individual. \nWith global thought leaders\, impactful research\, and opportunities for meaningful dialogue\, ICHNO 2026 will be a vital platform for education\, exchange\, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO)\, Giovanni Succo (EHNS)\, and Yungan Tao (ESMO). \nMore posts featuring European Society for Radiotherapy and Oncology on OncoDaily.
URL:https://oncodaily.com/event/the-ichno-2026-332267
LOCATION:Fibes – Conference and Exhibition\, Ave. Alcalde Luis Uruñuela\, 1\, Seville\, 41020\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/IMG_7601.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260326
DTSTAMP:20260507T211106
CREATED:20251228T200222Z
LAST-MODIFIED:20251228T200236Z
UID:10000539-1774396800-1774483199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25\, 2026\, focused on the practical application of clinical practice guidelines in the management of endometrial cancer. \nChaired by Ana Oaknin\, the webinar features a multidisciplinary panel of experts who discuss the diagnosis\, staging\, and therapeutic sequencing for endometrial malignancies through the lens of a real-world clinical case. The session provides oncology professionals with 1 ESMO-MORA category 1 point and serves as a forum for translating the latest ESMO Clinical Practice Guidelines into individualized patient care. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-435260
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20260325T080000
DTEND;TZID=Europe/Copenhagen:20260328T170000
DTSTAMP:20260507T211106
CREATED:20250712T062245Z
LAST-MODIFIED:20250712T062307Z
UID:10000211-1774425600-1774717200@oncodaily.com
SUMMARY:The European Lung Cancer Congress (ELCC 2026)
DESCRIPTION:The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen\, Denmark\, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science\, sharing education\, and enhancing lung cancer care practices globally. \nWith a comprehensive programme designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians\, interventional radiologists\, and pathologists\, ELCC 2026 offers valuable learning and networking opportunities. Participants are invited to engage in interactive sessions and connect with lung cancer specialists from around the world.
URL:https://oncodaily.com/event/elcc-2026-327158
LOCATION:Bella Center\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7077.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260507T211106
CREATED:20251228T200812Z
LAST-MODIFIED:20251228T200821Z
UID:10000540-1774569600-1774742399@oncodaily.com
SUMMARY:ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing
DESCRIPTION:The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28\, 2026\, in Beijing\, China. \nCo-chaired by Giuseppe Curigliano and Binghe Xu\, this 1.5-day course is specifically designed for experienced oncologists and oncology specialists to deepen their understanding of CDK4/6 inhibition in both early and metastatic HR+/HER2- breast cancer settings. The course is accredited with 11 ESMO-MORA category 1 points\, serving as a vital platform for clinicians in the Asia-Pacific region to integrate the latest evidence into precision breast cancer management. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-435266
LOCATION:Beijing\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-3.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR